WCN26-3273 ASSESSMENT AND TREATMENT OF METABOLIC ACIDOSIS IN JAPANESE PATIENTS WITH CKD: DATA FROM THE JAPAN CHRONIC KIDNEY DISEASE DATABASE EXTENSION (J-CKD-DB-EX)

Read full text Summarise with VIRAT
Authors: Mai Tanaka, Michihiro Hosojima, Hideyuki Kabasawa, Shin Goto, Seiji Itano, Seiji Kishi, Hajime Nagasu, Naoki Kashihara, Suguru Yamamoto
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Metabolic acidosis (MA) is common in patients with chronic kidney disease (CKD) and has been identified as a risk factor for CKD progression. It is also associated with adverse effects such as altered skeletal metabolism, insulin resistance, and protein-energy wasting. According to guidelines, both pharmacological therapy and dietary interventions aimed at reducing dietary acid load are recommended for the management of MA in CKD patients. However, reports from Western countries have suggested that MA is often underdiagnosed and undertreated.

Fields of Study & Subjects

Renal function and acid-base balance Kidney Stones and Urolithiasis Treatments Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103819–103819
Publication date
25 March 2026
Language
EN